PATENT CLAIM ANALYSIS

Application Number: 16021973
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "220000"]

Abstract:
Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.

Claim (Index 21):
The method of  claim 11 , wherein the parenteral administration comprises rectal administration, nasal administration, oral spray administration, transdermal administration, or transmucosal administration.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15995875', '15903529', '15903615', '14281288', '12860846']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8006342806722391
- 35 USC 102 Novelty (BERT): 0.5390729548194708
- Combined Prediction Score: 0.7744781480869622
- Mean Citation Score: 284.183712
- Max Citation Score: 375.12076
- Similarity Product: 237.62765796499488

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test